Lenz & Staehelin advises Lonza on large-scale commercial installation in Stein

Novartis Pharma Stein has sold a building right on part of its industry area in Stein to Lonza. The SIX-listed Lonza Group has announced that it plans to construct a large-scale, commercial drug product fill & finish facility in the Stein building. The investment will allow Lonza to provide customers with a complete and integrated end-to-end solution that includes commercial drug manufacturing for large-scale market supply. The new facility will be funded by an investment of approx. CHF 500 million and is expected to be completed in 2026.

Lenz & Staehelin is advising Lonza in this transaction. The team includes Fabiano Menghini (partner, co-head of real estate, pictured), associate Rebecca Rötheli as well as Noémie Ammann and Jan Küng.

Bär & Karrer acted as legal advisor to Novartis in this transaction. The team included Corrado Rampini and Kilian Müller (both real estate).

Corrado Rampini, partner Bär & Karrer
Lenz & Staehelin advises Lonza on large-scale commercial installation in Stein



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram